Cytosorbents Corporation develops medical devices using blood purification technology. CytoSorb is its flagship product for treating sepsis and other critical care applications. VetResQ is used to treat sepsis, pancreatitis, and other illnesses in animals. The company also develops CytoSorb-XL, HemoDefend, K+ontrol, ContrastSorb, BetaSorb, DrugSorb, and DrugSorb-ATR devices. These products are designed for various uses, including treating sepsis, hyperkalemia, and removing contaminants from blood. The company was founded in 1997 and is headquartered in Princeton, New Jersey.
| Indicator | Value |
|---|---|
| PER | 100.0 |
| EV/EBITDA | 100.0 |
| Price/Free Cash Flow' | 100.0 |
| ROIC | -% |
| Net Debt/EBITDA | 100.0 |